Advancement in Imaging for Radiation Oncology
Various advances in imaging are changing the clinical practice for Radiation Oncology. Different imaging technologies could offer additional information compared to the conventional CT image including but not limited to functional, metastasis-specific, real time, high soft tissue contrast imaging. Using these images for radiation oncology could help improve target and organ at risk contouring, outcome prediction and study, and improve the quality of overall radiation therapy. Despite its potential benefits, novel imaging techniques bring new challenges in radiation oncology. The intent of this session is to educate the audience of advancement in the following imaging modalities with their application in radiation oncology: 1) PSMA PET and multimodality imaging; 2) Multiparametric MRI; and 3) Dual Energy CT.
Topics:
- Introductions
Xun Jia, PhD - PSMA-supported EBRT for prostate cancer
Wouter Vogel, MD, PhD - Multiparametric MRI in Radiation Oncology
Yue Cao, PhD, FAAPM - Applications of DECT in Radiation Therapy
Jessica Miller, PhD - Q and A
Full Panel
This activity is available from April 30, 2024, through 11:59 p.m. Eastern time on April 29, 2026.
This activity was originally recorded at the 2023 ASTRO Annual Meeting.
Target Audience
The activity is designed to meet the interests of radiation oncologists, physicists, dosimetrists, and residents.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the value of various imaging modalities for radiation oncology applications.
- Identify issues that are unique to various imaging modalities, and possible solutions to these issues.
- Discuss the scope and limitation of various imaging modalities.
- Xun Jia, PhD, is employed by Johns Hopkins University School of Medicine. Dr. Jia receives grant/research funding from NIH.
- Wouter Vogel, MD, PhD, is employed by The Netherlands Cancer Institute. Dr. Vogel receives grant/research funding from Novartis.
- Yue Cao, PhD, FAAPM, is employed by the University of Michigan. Dr. Cao receives grant/research funding from NIH and Siemens Healthineers.
- Jessica Miller, PhD, is employed by University of Wisconsin Hospitals and Clinics. Dr. Miller receives grant/research funding from Siemens Healthiness Collaboration and GE Healthcare Collaboration. Dr. Miller serves in an uncompensated position on the advisory boards of UWADCL and SI Physics.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
Nonmember: $149
Member: $99
Member-in-training: $49
Student/Grad Student/PGY: $49
Postdoctoral Fellow: $49
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until April 29, 2026, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.